'life science' Tag

• The 3 broken arrows of growth capital in France

  June 11, 2013

  The other day during a stimulating conversation with five of French tech’s movers and shakers, the subject came up about the challenges facing high-potential tech firms in need of growth capital. Setting aside the Yahoo/DailyMotion debacle for a moment (which I fear will carry disastrous long-term consequences for cross-border m&a, one of the three ‘arrows’), […]

  posted in technology, venture capital by mark bivens